Endocrinology, Vol 137, 2441-2446, Copyright © 1996 by Endocrine Society

ARTICLES

Effect of tumor necrosis factor-alpha on insulin action in cultured rat skeletal muscle cells

N Begum and L Ragolia
Diabetes Research Laboratory, Winthrop University Hospital, Mineola, New York 11501, USA.

In this study, the acute effects of tumor necrosis factor (TNF)-alpha on insulin-stimulated glucose uptake, glycogen synthesis, and protein phosphatase-1 (PP-1) activation were examined in cultured rat skeletal muscle cell line, L6. Exposure of L6 cells to low concentrations of TNF- alpha (10 ng/ml for 60 min) inhibited basal and insulin stimulated 2- deoxyglucose uptake (40-50% decrease in basal and insulin stimulated glucose uptake respectively, when compared with controls, P < 0.05). The effect of TNF-alpha was more pronounced when the incubation period was extended to 6 and 12 h. TNF-alpha also blocked insulin activation of glycogen synthase (GS) and inhibited glycogen synthesis (measured as [14C]-glucose incorporated into glycogen). Because GS is activated by dephosphorylation via protein phosphatase-1 (PP-1), we examined the effect of TNF- alpha on PP-1 activation. As reported by us earlier (Srinivasan, M., and N. Begum, J Biol Chem 269:16662-16667, 1994), insulin rapidly stimulated PP-1 and concomitantly inhibited PP-2A activities in L6 cells. Pretreatment with TNF- alpha for 10-60 min blocked subsequent insulin-induced activation of PP-1. The impaired activation of PP-1 was accompanied by a reduction in insulin-stimulated phosphorylation of the regulatory subunit of PP-1. cAMP-Rp diastereomer, a cAMP antagonist failed to prevent the detrimental effects of TNF-alpha on PP-1. Cell permeable ceramide analogs, C2, C6, and Sphingomyelinase mimicked the effects of TNF-alpha on PP-1 inhibition. Furthermore, TNF-alpha treatment was accompanied by an increase in cellular ceramide levels, with concomitant reductions in sphingomyelin. We conclude that TNF-alpha blocks insulin-stimulated glycogen synthesis by inhibiting PP-1 activation via ceramide release.

This article has been cited by other articles:

				N. Roher, V. Samokhvalov, M. Diaz, S. MacKenzie, A. Klip, and J. V. Planas The Proinflammatory Cytokine Tumor Necrosis Factor-{alpha} Increases the Amount of Glucose Transporter-4 at the Surface of Muscle Cells Independently of Changes in Interleukin-6 Endocrinology, April 1, 2008; 149(4): 1880 - 1889. [Abstract] [Full Text] [PDF]

				N. Ghosh, N. Patel, K. Jiang, J. E. Watson, J. Cheng, C. E. Chalfant, and D. R. Cooper Ceramide-Activated Protein Phosphatase Involvement in Insulin Resistance via Akt, Serine/Arginine-Rich Protein 40, and Ribonucleic Acid Splicing in L6 Skeletal Muscle Cells Endocrinology, March 1, 2007; 148(3): 1359 - 1366. [Abstract] [Full Text] [PDF]

				D. L. Williamson, S. R. Kimball, and L. S. Jefferson Acute treatment with TNF-{alpha} attenuates insulin-stimulated protein synthesis in cultures of C2C12 myotubes through a MEK1-sensitive mechanism Am J Physiol Endocrinol Metab, July 1, 2005; 289(1): E95 - E104. [Abstract] [Full Text] [PDF]

				S. E. Borst, Y. Lee, C. F. Conover, E. W. Shek, and G. J. Bagby Neutralization of tumor necrosis factor-{alpha} reverses insulin resistance in skeletal muscle but not adipose tissue Am J Physiol Endocrinol Metab, November 1, 2004; 287(5): E934 - E938. [Abstract] [Full Text] [PDF]

				C. M. Wheatley, S. Rattigan, S. M. Richards, E. J. Barrett, and M. G. Clark Skeletal muscle contraction stimulates capillary recruitment and glucose uptake in insulin-resistant obese Zucker rats Am J Physiol Endocrinol Metab, October 1, 2004; 287(4): E804 - E809. [Abstract] [Full Text] [PDF]

				J. W. Helge, A. Dobrzyn, B. Saltin, and J. Gorski Exercise and training effects on ceramide metabolism in human skeletal muscle Exp Physiol, January 1, 2004; 89(1): 119 - 127. [Abstract] [Full Text] [PDF]

				J.-P. Tessier, B. Thurner, E. Jungling, A. Luckhoff, and Y. Fischer Impairment of glucose metabolism in hearts from rats treated with endotoxin Cardiovasc Res, October 15, 2003; 60(1): 119 - 130. [Abstract] [Full Text] [PDF]

				L. Zhang, C. M. Wheatley, S. M. Richards, E. J. Barrett, M. G. Clark, and S. Rattigan TNF-{alpha} acutely inhibits vascular effects of physiological but not high insulin or contraction Am J Physiol Endocrinol Metab, September 1, 2003; 285(3): E654 - E660. [Abstract] [Full Text] [PDF]

				J. GORSKI, A. DOBRZYN, and M. ZENDZIAN-PIOTROWSKA The Sphingomyelin-Signaling Pathway in Skeletal Muscles and Its Role in Regulation of Glucose Uptake Ann. N.Y. Acad. Sci., June 1, 2002; 967(1): 236 - 248. [Abstract] [Full Text] [PDF]

				M. Iwata, T. Haruta, I. Usui, Y. Takata, A. Takano, T. Uno, J. Kawahara, E. Ueno, T. Sasaoka, O. Ishibashi, et al. Pioglitazone Ameliorates Tumor Necrosis Factor-{alpha}-Induced Insulin Resistance by a Mechanism Independent of Adipogenic Activity of Peroxisome Proliferator-Activated Receptor-{gamma} Diabetes, May 1, 2001; 50(5): 1083 - 1092. [Abstract] [Full Text]

				R. Halse, S. L. Pearson, J. G. McCormack, S. J. Yeaman, and R. Taylor Effects of Tumor Necrosis Factor-{alpha} on Insulin Action in Cultured Human Muscle Cells Diabetes, May 1, 2001; 50(5): 1102 - 1109. [Abstract] [Full Text]

				T. P. Ciaraldi, L. Carter, S. Mudaliar, P. A. Kern, and R. R. Henry Effects of Tumor Necrosis Factor-{alpha} on Glucose Metabolism in Cultured Human Muscle Cells from Nondiabetic and Type 2 Diabetic Subjects Endocrinology, December 1, 1998; 139(12): 4793 - 4800. [Abstract] [Full Text] [PDF]

				A. Katsuki, Y. Sumida, S. Murashima, K. Murata, Y. Takarada, K. Ito, M. Fujii, K. Tsuchihashi, H. Goto, K. Nakatani, et al. Serum Levels of Tumor Necrosis Factor-{alpha} Are Increased in Obese Patients with Noninsulin-Dependent Diabetes Mellitus J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 859 - 862. [Abstract] [Full Text]

				R. A. Frost, C. H. Lang, and M. C. Gelato Transient Exposure of Human Myoblasts to Tumor Necrosis Factor-{alpha} Inhibits Serum and Insulin-Like Growth Factor-I Stimulated Protein Synthesis Endocrinology, October 1, 1997; 138(10): 4153 - 4159. [Abstract] [Full Text] [PDF]

				M. Van Epps-Fung, J. Williford, A. Wells, and R. W. Hardy Fatty Acid-Induced Insulin Resistance in Adipocytes Endocrinology, October 1, 1997; 138(10): 4338 - 4345. [Abstract] [Full Text] [PDF]

				C. Furnsinn, S. Neschen, O. Wagner, M. Roden, M. Bisschop, and W. Waldhausl Acute and Chronic Exposure to Tumor Necrosis Factor-{alpha} Fails to Affect Insulin-Stimulated Glucose Metabolism of Isolated Rat Soleus Muscle Endocrinology, July 1, 1997; 138(7): 2674 - 2679. [Abstract] [Full Text] [PDF]

				L. Ragolia and N. Begum The Effect of Modulating the Glycogen-Associated Regulatory Subunit of Protein Phosphatase-1 on Insulin Action in Rat Skeletal Muscle Cells Endocrinology, June 1, 1997; 138(6): 2398 - 2404. [Abstract] [Full Text] [PDF]